Literature DB >> 17133117

Acute severe asthma: recent advances.

Vaidehi Kaza1, Venkata Bandi, Kalpalatha K Guntupalli.   

Abstract

PURPOSE OF REVIEW: Acute severe asthma is challenging to the clinician both in terms of recognition and appropriate treatment. About 30% of these episodes need admission to the medical intensive care unit with a mortality of 8%. Relapse rates vary from 7 to 15% depending on how well the patient is managed. The purpose of this review is to discuss recent advances in identification of risk factors, pathophysiology and management of acute severe asthma. RECENT
FINDINGS: Although the exact mechanism for acute severe asthma is unclear, some that are implicated include inflammation, airway remodeling and downregulation of beta-receptors. None of the environmental factors have been clearly related to the development of near fatal attacks. Genetic polymorphisms have been associated with severe asthma. Lack of steroid responsiveness has been linked to severe asthma attacks. Chemokines and basement membrane changes characteristic of severe asthma are reported in a few studies. Lack of symptom perception in a certain group of patients with acute severe asthma leads to delayed interventions. Specific treatment modalities and ventilator management is reviewed.
SUMMARY: Severe asthma is a phenotype of asthma with variable pathology and clinical presentation. Early recognition and timely intervention is needed to prevent significant mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133117     DOI: 10.1097/MCP.0b013e328011a91c

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  9 in total

Review 1.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.

Authors:  Urs Frey; Béla Suki
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

3.  FoxO1 is a critical regulator of M2-like macrophage activation in allergic asthma.

Authors:  Sangwoon Chung; Ji Y Kim; Min-Ae Song; Gye Y Park; Yong G Lee; Manjula Karpurapu; Joshua A Englert; Megan N Ballinger; Navjot Pabla; Hae Y Chung; John W Christman
Journal:  Allergy       Date:  2018-11-05       Impact factor: 13.146

4.  Salbutamol-induced severe lactic acidosis in acute asthma.

Authors:  Hamza Najout; Mohamed Moutawakil; Abdelghafour Elkoundi; Nawfal Doghmi; Hicham Bekkali
Journal:  SAGE Open Med Case Rep       Date:  2020-10-28

5.  Efficacy of a loading dose of IV salbutamol in children with severe acute asthma admitted to a PICU: a randomized controlled trial.

Authors:  Shelley A Boeschoten; Corinne M P Buysse; Brenda C M de Winter; Joost van Rosmalen; Johan C de Jongste; Rogier C de Jonge; Sabien G J Heisterkamp; Job B van Woensel; Martin C J Kneyber; Annelies van Zwol; Annemie L M Boehmer; Matthijs de Hoog
Journal:  Eur J Pediatr       Date:  2022-08-03       Impact factor: 3.860

Review 6.  Emergency presentation and management of acute severe asthma in children.

Authors:  Knut Øymar; Thomas Halvorsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-04       Impact factor: 2.953

Review 7.  Is ketamine a lifesaving agent in childhood acute severe asthma?

Authors:  Mohamed A Hendaus; Fatima A Jomha; Ahmed H Alhammadi
Journal:  Ther Clin Risk Manag       Date:  2016-02-22       Impact factor: 2.423

8.  Children with severe acute asthma admitted to Dutch PICUs: A changing landscape.

Authors:  Shelley A Boeschoten; Corinne M P Buysse; Peter J F M Merkus; Jacob M C van Wijngaarden; Sabien G J Heisterkamp; Johan C de Jongste; Joost van Rosmalen; Suzan C M Cochius-den Otter; Annemie L M Boehmer; Matthijs de Hoog
Journal:  Pediatr Pulmonol       Date:  2018-04-10

9.  A Loading Dose of IV Salbutamol in an Adolescent with Severe Acute Asthma and Cardiac Arrest.

Authors:  Shelley A Boeschoten; Ruben S van der Crabben; Annemie L M Boehmer; Matthijs de Hoog; Corinne M P Buysse
Journal:  Case Rep Pediatr       Date:  2019-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.